
Myebine 500 Tablet
Marketer
Bruck Pharma Pvt Ltd
Salt Composition
Capecitabine (500mg)
Overview Myebine 500 Tablet
Oncasin 500mg tablets are indicated for the management of breast, colorectal, and rectal cancers. Additional uses may be determined by a physician. It's administered as a single agent or in combination with other medications within a chemotherapy regimen. Oncasin 500mg should be ingested with food, within 30 minutes post-meal. Dosage and frequency are physician-determined, based on the specific condition and may vary. Strict adherence to the prescribed regimen is crucial; improper use or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for several weeks or months; discontinue use only under medical supervision. Common side effects include emesis, fatigue, nausea, abdominal discomfort, and diarrhea. This medication can reduce blood cell counts (specifically white blood cells), increasing infection risk. Regular blood tests to monitor blood cell counts, along with cardiac, hepatic, and uric acid levels are essential. Prior to commencing treatment, inform your physician of any pre-existing hepatic or renal dysfunction, or concurrent use of anti-infective medications. Drug interactions are possible; disclose all medications currently being taken. This medication is contraindicated in pregnancy and lactation. Reliable contraception is advised for both partners throughout the treatment period to prevent conception.
Primary Ingredients of Myebine 500 Tablet
The provided text is "undefined," therefore no rewriting is possible.
Uses of Myebine 500 Tablet
Cancers affecting the breast and colorectal regions
Major Benefits of Myebine 500 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Myebine 500 Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with food.
Common Side effects of Myebine 500 Tablet:
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Diarrhea
- Blisters on fingers/feet
How to use Myebine 500 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Myebine 500 Tablet with a meal.
How Myebine 500 Tablet works:
Myebine 500 Tablets contain an anticancer agent that metabolizes into 5-fluorouracil. This substance inhibits the production of RNA and DNA within cancerous cells, disrupting their replication and growth processes. Consequently, cancer cell proliferation is reduced, leading to their eventual demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Myebine 500 Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Myebine 500 Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is discouraged. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice before use.
Breast feedingUNSAFE
Lactation and Myebine 500 Tablet are incompatible; the medication poses a potential risk of infant toxicity.
DrivingUNSAFE
Taking Myebine 500 Tablets might reduce awareness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should use Myebine 500 Tablets cautiously, potentially requiring dosage modification under medical supervision. Myebine 500 Tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Myebine 500 Tablets cautiously, potentially requiring dosage modification under medical supervision. Myebine 500 Tablets are contraindicated in individuals with severe renal dysfunction.
What if you forget to take Myebine 500 Tablet :
NA
Facts to Know About Myebine 500 Tablet
| Label | Value |
|---|---|
| Chemical Category | Modified Deoxycytidine |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
| Actions | Metabolic inhibitors |
